Lower riskDrug recall · FDA · Published July 5, 2022
Mylan Insulin Pens Missing Labels - Recalled for Safety
Mylan recalls insulin pens with missing labels to prevent medication errors. Affected pens have specific NDC numbers and were sold with expiration dates through August 2023.
“Mylan Insulin Pens Missing Labels - Recalled for Safety.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34438-mylan-insulin-pens-missing-labels-recalled-for-safety. Based on FDA recall #D-1292-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1292-2022%22&limit=1).
Mylan Pharmaceuticals Inc. voluntarily recalled Insulin Glargine prefilled pens on July 5, 2022, after the FDA announced that some units lacked required labeling, according to the FDA.
The recall addresses the hazard of missing labels on some prefilled pens, which could lead to medication errors, according to the FDA.
Context
GovInfoNow's records show Mylan Pharmaceuticals Inc. has 54 other recalls on record since June 28, 2012. Recent Mylan recalls include failed dissolution specifications for Mycophenolate Mofetil Injections (Aug. 26, 2026) and Prasugrel Tablets (Aug. 17, 2026), as well as Acamprosate Tablets (July 24, 2026). Other recent recalls of similar products include CAPS TPN Bag Recall (Dec. 27, 2025) and American Regent Levocarnitine Injection Recall (April 16, 2026).
How to tell if you have this one
Check for the NDC numbers 49502-394-71 (pens) and 49502-394-75 (cartons of 5 pens). These pens were sold with an expiration date of August 2023.
Brand
Mylan
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Label
Look for a label on the pen; if missing, it is part of the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Product was distributed nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1292-2022 (July 5, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1292-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.